Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot blot hybridization strategy

Tubercle and Lung Disease

Volumn 79, Issue 6, 1999, Pages 343-348

  Victor, T C ^a   Jordaan, A M ^a   Van Rie, A ^a   Van Der Spuy, G D ^a   Richardson, M ^a   Van Helden, P D ^a   Warren, R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; DOT HYBRIDIZATION; DRUG RESISTANCE; GENE LOCUS; GENE MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; SOUTH AFRICA; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 0032748409     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1999.0222     Document Type: Article

References (26)

1. Culliton B J. Drug-resistant TB may bring epidemic. Nature (London). 356:1992;473.
2. Shinnick, T, M, Jonas, V, Molecular approaches to the diagnosis of tuberculosis p517-530, Bloom, B, R, Tuberculosis: pathogenesis protection and control, ASM Press, Washington DC.
3. Shinnick, T, M, Jonas, V, Molecular approaches to the diagnosis of tuberculosis p517-530, Bloom, B, R, Tuberculosis: pathogenesis protection and control, ASM Press, Washington DC.
4. Rastogi N, Goh K S, David H L. Drug susceptibility testing in tuberculosis: a comparison of the proportion method using Löwenstein-Jensen Middlebrook 7H10 and 7H11 agar media and a radiometric method. Res Microbiol. 140:1989;405-417.
5. Siddiqi S H, Hawkins J E, Laszlo A. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by radiometric procedure and two conventional methods. J Clin Microbiol. 22:1985;919-923.
6. Snider D E, Good R C, Kilburn J O. Rapid susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis. 123:1981;402-416.
7. Tarrant J J, Groschel D H M. Evaluation of the BACTEC radiometric method for detection of 1% resistant population of Mycobacterium tuberculosis. J Clin Microbiol. 21:1985;941-946.
8. Victor T C, Warren R, Butt J L. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis. J Med Microbiol. 46:1997;847-957.
9. Martin-Casabona N, Mimó D X, González T, Rossello J, Arcalis L. Rapid method for testing susceptibility of Mycobacterium tuberculosis by using DNA probes. J Clin Microbiol. 35:1997;2521-2525.
10. Musser J M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev. 8:1995;496-514.
11. Felmlee T A, Lin Q, Whelen A C. Genomic detection of Mycobacterium tuberculosis rifampicin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol. 33:1995;1617-1623.
12. Williams D L, Wagnespack C, Eisenach K. Characterization of rifampicin resistance in pathogenic mycobacteria. Antimicrob Agents Chemother. 38:1994;2380-2386.
13. Wegenack N L, Uhl J R, St Amand A L. Recombinant Mycobacterium tuberculosis KatG (S315T) is a competent catalase peroxidase with reduced activity towards isoniazid. J Infect Dis. 176:1997;722-727.
14. Telenti A, Imboden P, Marchesi F. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 341:1993;647-650.
15. De Beenhouwer H, Lhiang Z, Jannes G. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle and Lung Disease. 76:1995;425-430.
16. Rossau K, Traore H, De Beenhouwer H. Evaluation of the INNO-LIPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection ofMycobacterium tuberculosis complex and its resistance to Rifampicin. Antimicrob Agents Chemother. 41:1997;2093-2098.
17. Fisher, S, Western Cape Regional Services Council. Annual Report of the Department of Health Services, South Africa, 1990, 35, 51.
18. Pretorius G S, van Helden P D, Sirgel F, Eisenach K D, Victor T C. Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare. Antimicrob Agents Chemother. 39:1995;2276-2281.
19. Persing, D, H, Smith, T, F, Tenover, F, C, White, T, J, Diagnostic molecular microbiology: principles and applications, 1993, 3, 160.
20. Victor T, du Toit R, Jordaan A M, Bester A J, van Helden P D. No evidence for point mutations on codons 12, 13 and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers. Cancer Research. 50:1990;4911-4911.
21. Sreevatsan S, Stockbauer K E, Pan X I. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother. 41:1997;1677-1681.
22. Sreevatsan S, Pan X, Stockbauer K E. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionary recent global dissemination. Proc Natl Acad Sci. 94:1997;9869-9874.
23. Mdluli K, Slayden R A, Zhu Y. Inhibition of a Mycobacterium tuberculosisβ-ketoacyl ACP synthetase by isoniazid. Science. 280:1998;1607-1610.
24. Dobner P, Bretzel G, Rüsch-Gerdes S. Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance inMycobacterium tuberculosis. Mol Cell Probes. 11:1997;123-126.
25. Telenti A, Honoré N, Bernasconi C. Genotype assessment of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol. 35:1997;719-723.
26. Telenti A, Phillip W J, Sreevatsan S. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nature Med. 3:1997;567-570.